Table 4.
HCRU in the 4 weeks after index stratified by age, risk of severe COVID-19 and immunocompromised status at baseline among the primary care cohort
| HCRU | All (n=1 693 263) |
Age stratifications | Risk criteria | Immunocompromised status at baseline | ||||
| 18–49 (n=1 161 843) |
50–64 (n=379 528) |
65–74 (n=92 573) |
75–84 (n=40 481) |
≥85 (n=18 838) |
Green Book (n=212 556) | Immunocompromised (n=63 547) | ||
| Any COVID-19 medication use: n (%) | 253 (<1.0) | 69 (<1.0) | 63 (<1.0) | 33 (<1.0) | 39 (0.1) | 49 (0.3) | 116 (0.1) | 51 (0.1) |
| Primary care consultations—F2F: number with >1 visit (%) | 71 039 (4.2) |
39 108 (3.4) | 19 330 (5.1) | 6491 (7.0) | 3726 (9.2) | 2384 (12.7) | 17 237 (8.1) | 4587 (7.2) |
| Primary care consultations—telephone: number with >1 call (%) | 137 148 (8.1) |
70 675 (6.1) | 40 311 (10.6) | 13 434 (14.5) | 7860 (19.4) | 4868 (25.8) | 36 852 (17.3) | 9375 (14.8) |
F2F, face to face; HCRU, healthcare resource utilisation.